Tag: novan

October 8, 2019

5 Top NASDAQ Pharma Stocks Year-to-Date

With Q4 in full swing, it's time to reflect on the top-performing NASDAQ pharma stocks year-to-date.
October 8, 2019

Novan’s Phase 2 SB206 Study Published in Journal of American Academy of Dermatology

The company's results from its Phase 2 SB206 trial were published in the Journal of the American Academy of Dermatology.
August 13, 2019

Novan Completes Phase 3 Enrollment for Molluscum Pivotal Program

Novan (NASDAQ:NOVN) has announced it has completed enrollment of its ongoing B-SIMPLE Phase 3 pivotal trials of SB206 to treat...
May 26, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Sesen Bio Up 40 Percent

Which NASDAQ biotech and pharma stocks were up last week? We examine the top five gainers and what may have...
December 11, 2018

Novan to Present Data from SB414 Phase 1b Atopic Dermatitis Clinical Trial at 3rd Inflammatory Skin Disease Summit

Novan (NASDAQ:NOVN) announced that clinical results from the Company’s Phase 1b trial with SB414 cream for the treatment of atopic...
October 1, 2018

Novan’s Phase 2 Molluscum Contagiosum Trial Fully Enrolled: Top Line Results Targeted in November

Novan (Nasdaq:NOVN) today announced that enrollment in the Company’s Phase 2 clinical trial to evaluate topical nitric oxide product candidate...
August 20, 2018

Novan Announces Promising Clinical Results with SB414

Novan (Nasdaq:NOVN) announced an update on the SB414 nitric oxide-releasing cream product candidate and its application to two therapeutic indications:...